AQR Capital Management
CBMG

AQR Capital Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

AQR Capital Management’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,293
Closed -$242K – 2315
2015
Q4 		$242K Sell
11,293
-3,845
-25% -$81.3K ﹤0.01% 2093
2015
Q3 		$256K Buy
15,138
+859
+6% +$21.4K ﹤0.01% 1977
2015
Q2 		$536K Buy
+14,279
New +$461K ﹤0.01% 1750

Other funds holding CBMG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

AQR Capital Management's CBMG Position: Q1 2016 in Review

AQR Capital Management sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2016, closing a stake of 11,293 shares — an estimated $242K sold.

AQR Capital Management first reported a position in CBMG in Q2 2015 and held it in 3 quarters. The position peaked at $536K in Q2 2015. 30 funds tracked by Wall St. Rank hold CBMG as of Q1 2016.

  • AQR Capital Management reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2016 after selling out during the quarter.
  • AQR Capital Management sold 11,293 Cellular Biomedicine Group, Inc. shares in Q1 2016, an estimated $242K.
  • AQR Capital Management first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 3 quarters.
  • AQR Capital Management's Cellular Biomedicine Group, Inc. position peaked at $536K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2016.

Based on AQR Capital Management's 13F filing for Q1 2016, filed 16 May 2016.